"It definitely got to a point where we could see what was happening in Europe and needed to start preparing for a likely response in Australia," said Charles Waterfield, the commercial excellence and innovation director at AstraZeneca Australia.
AZ's Charles Waterfield: The new world will be different to the one we left
May 13, 2020 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Medicines Australia chief says next negotiation is about getting comfortable with being uncomfortable
July 3, 2026 - - Latest News -
New once weekly therapy offers extended protection for people with haemophilia A
July 3, 2026 - - Latest News -
Nurse prescribing reform set to expand access to PBS subsidised medicines
July 3, 2026 - - Latest News -
Nothing else grows below this self-serving and broken institutional framework
July 3, 2026 - - Latest News -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News -
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy
July 2, 2026 - - Australian Biotech -
The end-game of strong-arming companies over prices at the expense of patients and process
July 2, 2026 - - Latest News

